Unrecognized Tax Benefits of Cidara Therapeutics, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Cidara Therapeutics, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Cidara Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2024 was $12,906,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Cidara Therapeutics, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $12,906,000 +$1,386,000 +12% 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q4 2023 $11,520,000 +$505,000 +4.6% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 $11,015,000 -$12,975,000 -54% 31 Dec 2022 10-K 06 Mar 2025 2024 FY
Q4 2021 $23,990,000 +$655,000 +2.8% 31 Dec 2021 10-K 22 Apr 2024 2023 FY
Q4 2020 $23,335,000 +$777,000 +3.4% 31 Dec 2020 10-K 23 Mar 2023 2022 FY
Q4 2019 $22,558,000 +$6,034,000 +37% 31 Dec 2019 10-K 23 Mar 2023 2022 FY
Q4 2018 $16,524,000 +$5,768,000 +54% 31 Dec 2018 10-K 07 Mar 2022 2021 FY
Q4 2017 $10,756,000 +$6,114,000 +132% 31 Dec 2017 10-K 25 Feb 2021 2020 FY
Q4 2016 $4,642,000 +$4,286,000 +1204% 31 Dec 2016 10-K 04 Mar 2020 2019 FY
Q4 2015 $356,000 +$248,000 +230% 31 Dec 2015 10-K 28 Feb 2019 2018 FY
Q4 2014 $108,000 +$102,000 31 Dec 2014 10-K 27 Feb 2018 2017 FY
Q4 2013 $6,000* +$6,000 31 Dec 2013 10-K 15 Mar 2017 2016 FY
Q4 2012 $0 31 Dec 2012 10-K 18 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.